Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04544501 · ClinicalTrials.gov registry record · NA
Enhance the Use of Genetic Counseling and Testing in Latinas
A NA study of Hereditary Breast and Ovarian Cancer Syndrome, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 4
- Study locations
NCT04544501 is a NA study of Hereditary Breast and Ovarian Cancer Syndrome that has completed, run by Georgetown University. The registered enrollment target is 61 participants. The trial reports 4 study locations across 2 states.
The verdict
NCT04544501, a NA study of Hereditary Breast and Ovarian Cancer Syndrome, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators will conduct a two-arm RCT to evaluate the preliminary effectiveness of a culturally-adapted video developed by the team vs. a FORCE fact sheet on enhancing genetic cancer risk assessment (GCRA; including genetic counseling and option for genetic testing) uptake and psychosocial outcomes among Latinas at increased risk for hereditary breast and ovarian cancer (HBOC).
Conditions Studied
Interventions
- BEHAVIORAL Culturally-Targeted Video
- OTHER FORCE Fact Sheet
Study Locations (4)
Virginia
- Nueva Vida - Alexandria
- Arlington Free Clinic - Arlington
- Virginia Commonwealth University - Richmond
District of Columbia
- Capital Breast Care Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04544501
The ClinicalTrials.gov registry entry for NCT04544501 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hereditary Breast and Ovarian Cancer Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Culturally-Targeted Video is the first listed.
NCT04544501 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Virginia, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04544501 about?
NCT04544501 is a clinical study titled "Enhance the Use of Genetic Counseling and Testing in Latinas". The investigators will conduct a two-arm RCT to evaluate the preliminary effectiveness of a culturally-adapted video developed by the team vs. a FORCE fact sheet on enhancing genetic cancer risk assessment (GCRA; including genetic counseling and option for genetic testing) uptake and psychosocial ou...
What is the current status of trial NCT04544501?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2020-02-24. Estimated completion is 2022-01-31.
What conditions does trial NCT04544501 study?
This clinical trial studies the following conditions: Hereditary Breast and Ovarian Cancer Syndrome.
What interventions are being tested in trial NCT04544501?
The interventions under investigation include: Culturally-Targeted Video (BEHAVIORAL), FORCE Fact Sheet (OTHER).
Who is sponsoring clinical trial NCT04544501?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04544501 being conducted?
This trial has 4 study locations across District of Columbia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Breast and Ovarian Cancer Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.